Previous Article | Next Article 
Infection and Immunity, December 1998, p. 5792-5798, Vol. 66, No. 12
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Relationship of Structure and Biological Activity
of Monosaccharide Lipid A Analogues to Induction of Nitric Oxide
Production by Murine Macrophage RAW264.7 Cells
Keiji
Funatogawa,1
Motohiro
Matsuura,1,*
Masayasu
Nakano,1
Makoto
Kiso,2 and
Akira
Hasegawa2,
Department of Microbiology, Jichi Medical
School, Tochigi 329-0498,1 and
Department of Applied Bioorganic Chemistry, Gifu
University, Gifu 501-1112,2 Japan
Received 4 June 1998/Returned for modification 2 July 1998/Accepted 27 September 1998
 |
ABSTRACT |
Lipid A is the active center of bacterial lipopolysaccharide (LPS),
which exhibits diverse biological activities via the production of
various mediators. We investigated the production of nitric oxide (NO),
one of the mediators, by a murine macrophage cell line, RAW264.7, upon
stimulation with a series of monosaccharide lipid A analogues to
elucidate the relationship of structure and activity in NO production.
The production of other representative mediators, such as tumor
necrosis factor alpha (TNF-
) and interleukin-6 (IL-6), was also
investigated to compare the structural requirements for the production
of these cytokines with those for the production of NO.
Structure-activity relationships in NO production correlated well with
those in the production of TNF-
and IL-6. Among the lipid A
analogues possessing different numbers of acyl groups on a
4-O-phosphono-D-glucosamine backbone, compounds
like GLA-60 that possess three tetradecanoyl (C14) groups
exhibited stronger activities in the production of the mediators than
compounds possessing four or two C14 groups. Time course
study of the production of these mediators showed that production of NO
started and peaked later than those of TNF-
and IL-6. Neither
neutralization of TNF-
activity by antibody nor suppression of
TNF-
production by pentoxifylline showed a significant suppressive
effect on production of NO and IL-6 upon stimulation with LPS or lipid
A analogues. Neutralization of IL-6 activity by antibody showed no
significant suppressive effect on production of NO and TNF-
. A
monosaccharide lipid A analogue (GLA-58) which exhibited no detectable
agonistic activity showed a suppressive effect on the production of all three mediators upon stimulation with LPS or lipid A analogues. These
results indicate that signals for NO production by LPS agonists in
murine macrophages are transduced in good correlation with those for
production of TNF-
and IL-6, although they are not transduced via
production of those cytokines.
 |
INTRODUCTION |
Bacterial lipopolysaccharide (LPS)
in the outer membranes of gram-negative bacteria is the principal
component of endotoxin, which activates the host immune system and has
a variety of pathophysiological effects (18). Many of these
activities are mediated by various substances (mediators) that are
produced by macrophages and other cells after stimulation with LPS.
Cytokines and arachidonic acid metabolites are involved in such
mediators (13). In addition to these mediators, nitric oxide
(NO) has recently received considerable attention as a new type of
mediator (17).
The active center of LPS was revealed to be its lipid part, called
lipid A, by the use of chemically synthesized lipid A, which expressed
full endotoxic activities (4, 7, 11). In addition to the
compound with the complete lipid A structure, which was named 506, a
wide variety of structurally modified compounds were synthesized and
studied intensively for structure-activity relationships. We have shown
that the monosaccharide type of lipid A analogue, whose molecules are
about half the size of those of the complete lipid A with a
disaccharide structure, can exhibit various LPS activities but not
pyrogenicity (8, 16). Using a series of monosaccharide lipid
A analogues, we showed that the acylation patterns of the analogues as
well as the phosphorylation patterns play an important role in
biological activities (12), as is the case for disaccharide
analogues (3). The relationships of the structures and
activities of monosaccharide lipid A analogues in the production of
cytokines from murine macrophages have been studied in vitro and in
vivo, (8), but the ability of the analogues to induce NO
production was not studied in detail. Detailed studies of
structure-activity relationships in NO production with a series of
lipid A analogues are necessary to characterize the structural requirements for NO production, especially with regard to whether they are separable from those for production of the other
LPS-induced mediators. The results obtained from such studies will also
provide information for a better understanding of the characteristic
features of LPS-derived NO production.
In the present study, we aimed to clarify the structure-activity
relationship of monosaccharide lipid A analogues with different acylation patterns in the production of NO from murine macrophages, and
we compared it with those in the production of cytokines, such as tumor
necrosis factor alpha (TNF-
) and interleukin-6 (IL-6). The
activities of the analogues in NO production varied from strongly
positive to negative, depending on their structure, and the intensity
of activity correlated well with the production of cytokine, suggesting
the existence of closely related regulatory mechanisms between
signaling pathways for the production of NO and the production of
TNF-
and IL-6.
 |
MATERIALS AND METHODS |
Reagents.
The LPS, which was isolated and purified from
Salmonella abortus equi (5), was a kind gift from
C. Galanos, Max-Planck-Institut für Immunbiologie, Freiburg,
Germany. Synthetic lipid A, 506, was obtained from Daiichi Pure
Chemical Co. Ltd. (Tokyo, Japan). Monosaccharide lipid A analogues were
synthesized chemically as described elsewhere (9, 10). The
structures of these compounds are shown in Fig.
1, 2, and
3. These compounds were solubilized in
triethylamine salt form, stabilized with bovine serum albumin in
pyrogen-free distilled water as described previously (14), and stored at 4°C until use. Anti-mouse TNF-
antibody was kindly donated by Suntory Co. Ltd., Osaka, Japan. Anti-mouse IL-6 was purchased from Genzyme, Inc. (Cambridge, Mass.), and pentoxifylline (PTX) was purchased from Sigma Chemical Co. (St. Louis, Mo.).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 1.
Production of NO, TNF- , and IL-6 by RAW264.7 cells
after stimulation with lipid A (506) and a monosaccharide lipid A
analogue (GLA-60). RAW264.7 cells were cultured in the presence of 506 ( ) at 100 ng/ml or GLA-60 ( ) at 10 µg/ml. Culture supernatants
were obtained at the indicated times for measurement of NO, TNF- ,
and IL-6. The data are the means ± SEM of triplicate samples.
Similar results were obtained in another independent experiment.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 2.
Stimulation of RAW264.7 cells for production of NO,
TNF- , and IL-6 by monosaccharide lipid A analogues possessing
different numbers of acyl groups. RAW264.7 cells were cultured in the
presence of the indicated doses of lipid A analogues. As shown, GLA-26
( ), GLA-60 ( ), and GLA-47 ( ) possess 2, 3, and 4 acyl groups,
respectively. The amounts of NO, TNF- , and IL-6 in the culture
supernatants at 48 h were determined. The data are the means ± SEM of triplicate samples. A representative result of three
independent experiments is shown.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 3.
Effect of difference in acylation patterns of triacyl
monosaccharide lipid A analogues on stimulation of RAW264.7 cells to
produce mediators. The experimental procedures were basically the same
as those described in the legend to Fig. 2, except for the analogues
used. As shown, GLA-58 ( ), GLA-59 ( ), GLA-60 ( ), and GLA-69
( ) are all triacyl monosaccharide analogues, but their acylation
patterns are different. The data are the means ± SEM of
triplicate samples. Similar results were obtained in two other
independent experiments.
|
|
Cells and cell culture.
For cell culture, RPMI 1640 medium
(Flow Laboratories Co. Ltd., Rockville, Md.) supplemented with 10 mM
HEPES, 2 mM L-glutamine, 100 U of penicillin per ml, 100 µg of streptomycin per ml, and 0.2% NaHCO3 (culture
medium) was used. Cells from the murine macrophage cell line RAW264.7
(originally from the American Type Culture Collection, Rockville, Md.)
were maintained in culture medium supplemented with 10%
heat-inactivated fetal calf serum (Flow Laboratories) in a humidified
chamber at 37°C with 5% CO2. For stimulation experiments
with macrophages, culture medium supplemented with 1% fetal calf serum
was used. The cells were plated at 5 × 105/0.5
ml/well of 48-well tissue culture plates (Sumitomo Bakelite Co. Ltd.,
Tokyo, Japan) and incubated for at least 2 h in a cell culture
chamber to allow them to adhere to the plates. After being washed three
times with 0.5 ml of Hanks' balanced salt solution (Flow
Laboratories)/well, the cells were cultured in culture medium containing stimulants and/or inhibitors (final volume, 0.5 ml/well).
Measurement of NO production.
NO production by the
macrophages was measured as nitrite, a stable end product of NO, in the
culture supernatant. For the measurement of nitrite, 50 µl of Griess
reagent (0.1% N-1-naphthylenediamine dihydrochloride and
1% sulfanilamide in 2.5% phosphoric acid) (6) was added to
the same volume of culture supernatant in each well of 96-well plates,
mixed, and left at room temperature for 10 min. Absorbance was measured
at 540 nm with a Biomek 1000 spectrophotometer (Beckman Instruments,
Palo Alto, Calif.), and nitrite concentrations were quantified from the
standard curve with NaNO3.
Cytokine assays.
The amounts of TNF-
in the culture
supernatants of macrophages were quantified by a cytotoxic assay
against L-929 cells (21). Briefly, L-929 cells were
precultured in 96-well tissue culture plates (Nunc, Roskilde, Denmark)
for 2 to 3 h and then actinomycin D (Sigma Chemicals Co.) at a
final concentration of 1 µg/ml and serially diluted test samples were
added to the cultures. The viability of the cells after overnight
culture was determined by crystal violet staining and by measuring
absorbance at 540 nm with the Biomek 1000 spectrophotometer. TNF-
activity (in units per milliliter) was calculated from the dilution
factor of test samples necessary for 50% cell lysis, with correction by a recombinant human TNF-
internal standard in each assay.
The production of IL-6 by the macrophages was measured by determining
IL-6 activity in the culture supernatants with a proliferation assay of
an IL-6-dependent mouse hybridoma cell line, B13.29 (1). Briefly, B13.29 cells in 96-well tissue culture plates (Nunc) were
incubated with serial dilutions of test samples in a humidified chamber
at 37°C with 5% CO2. After 3 days of incubation, MTT
(3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; Sigma
Chemicals), a tetrazolium salt that is converted to formazan blue
crystals by metabolically active cells, was added for a further 4 h (19). The supernatant was removed from the wells, and the
formazan blue crystals produced by viable cells were dissolved with
isopropanol solution containing 5% formic acid. Absorbance was
measured at 540 nm with the Biomek 1000 spectrophotometer. IL-6
activity (in units per milliliter) was calculated as the dilution
factor required to induce 50% cell growth, with correction by an
internal standard of recombinant human IL-6.
Statistical analysis.
Data are expressed as means ± standard errors of the means (SEM) of triplicate samples. All
experiments were performed two or three times. The results were
analyzed by Student's t test, and a P value of
<0.05 was regarded as statistically significant.
 |
RESULTS |
Time course of NO, TNF-
, and IL-6 production by RAW264.7 cells
upon stimulation with a synthetic lipid A, 506, and a monosaccharide
lipid A analogue, GLA-60.
It was reported that murine macrophage
cell lines were useful models to study macrophage synthesis of NO and
that a macrophage cell line, RAW264.7, responded well to LPS-induced NO
synthesis (24). In the present study, RAW264.7 cells were
used to study the abilities of lipid A analogues to induce NO synthesis
in relation to their structures. The ability of the analogues to
produce cytokines, such as TNF-
and IL-6, was also examined.
RAW264.7 cells were stimulated with 506 at 100 ng/ml or GLA-60 at 10 µg/ml, and production of NO, TNF-
, and IL-6 in the culture
supernatant was measured at various times thereafter. As shown in Fig.
1, GLA-60 stimulated the cells to produce these three mediators in a
manner similar to that of 506. The production of NO was induced by
6 h, peaked at 24 h, and was sustained over 72 h.
Production of TNF-
and IL-6 had started by 2 h and peaked at
6 h for TNF-
and at 8 h for IL-6, and both peaks were
sustained over 72 h. Based on these results, culture supernatants
at 48 h were used for assays of all three mediators in subsequent
experiments. When thioglycollate-elicited murine peritoneal macrophages
were used instead of RAW264.7 cells, similar results were obtained,
although the maximum amounts of NO produced upon stimulation with
either 506 or GLA-60 were smaller (about 20 µM) than those produced
by RAW264.7 cells (over 60 µM). This weak production of NO by
thioglycollate-elicited murine peritoneal macrophages upon stimulation
with these compounds was enhanced in the presence of gamma interferon
(data not shown), as was reported in the case of LPS stimulation
(24).
Effect of the number of attached acyl groups in lipid A
analogues on production of NO, TNF-
, and IL-6 by RAW264.7
cells.
The stimulatory effects of monosaccharide lipid A analogues
on production of the three mediators were compared by using GLA-26, GLA-60, and GLA-47, which possess 2, 3, and 4 acyl groups,
respectively. The chemical structures of these analogues and the
results of the experiment are shown in Fig. 2. The strongest
stimulatory activity for production of the mediators was exhibited by
GLA-60, with three acyl groups. In the production of all three
mediators, GLA-60 induced weak, high, and higher production at 10, 100, and 1,000 ng/ml, respectively. Next to GLA-60, GLA-47, with four acyl groups, showed moderate activity. At a concentration of 100 ng of
GLA-47/ml, undetectable (NO) or weak (TNF-
and IL-6) production was
observed, and at 1,000 and 10,000 ng of GLA-47/ml, high and higher
production, respectively, of all three mediators was induced. The
activity of GLA-26, with two acyl groups, was much weaker than that of
GLA-47. Only weak production of the mediators was induced by GLA-26 at
the highest concentration tested (10,000 ng/ml). The ability of each
analogue to induce NO synthesis correlated very well with its ability
to induce TNF-
and IL-6 production.
Effects of different acylation patterns in triacyl
monosaccharide lipid A analogues on production of mediators by
RAW264.7 cells.
In addition to GLA-60, mentioned above, three
other triacyl monosaccharide lipid A analogues were introduced into
experiments, and their activities in the production of the three
mediators were compared with those of GLA-60. The structures and
activities of these analogues are shown in Fig. 3. In GLA-59, a
tetradecanoyl (C14) group attached to the hydroxy (OH)
group of the 3-O-linked 3-hydroxy-tetradecanoyl
(C14-OH) group in GLA-60 is transferred to the
2-N-linked C14-OH group. In GLA-69 and GLA-58, a
hexadecanoyl (C16) group is introduced instead of a
C14 group attached to the OH group of the 3-O-
and 2-N-linked C14-OH group in GLA-60 and GLA-59, respectively, and a free C14 group instead of a
free C14-OH group is introduced in both analogues.
Among the analogues, GLA-59 exhibited strong activities comparable to
those of GLA-60 in the induction of the three mediators.
GLA-69
exhibited only weak activities, i.e., it induced only weak
production
of all three mediators at the highest concentration
tested. No
significant activity of GLA-58 in the induction of
the mediators was
detected up to the highest concentration tested,
10,000 ng/ml. The
activity of each analogue to induce NO synthesis
again correlated very
well with its activities in TNF-

and IL-6
production. These results
suggest that signals for the production
of NO in response to
stimulation with lipid A analogues are transduced
in close relation
with those for the production of TNF-

and IL-6.
Effect of anti-TNF-
antibody and PTX on production of NO and
IL-6 by stimulation with LPS, 506, or GLA-60.
With the three
mediators tested in this study, accumulation of TNF-
in the culture
supernatant of RAW264.7 cells upon stimulation with 506 and GLA-60
peaked first (6 h), that of IL-6 peaked a little later (8 h), and that
of NO peaked much later (24 h) (Fig. 1). To investigate the effect of
previously produced TNF-
on the induction of NO synthesis, RAW264.7
cells were stimulated with LPS, 506, or GLA-60 in the presence of
anti-mouse TNF-
antibody, and NO in the culture supernatant was
measured. The activities of IL-6 and TNF-
in the culture supernatant
were also measured. As shown in Fig. 4,
anti-mouse TNF-
antibody showed no suppressive effect on the
production of NO and IL-6, while it suppressed the TNF-
activity in
the culture supernatant in a dose-dependent manner.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 4.
Effect of anti-TNF- antibody on production of
mediators by RAW264.7 cells upon stimulation with LPS, 506, and GLA-60.
RAW264.7 cells were cultured in the presence of the indicated
concentrations of anti-TNF- antibody. The cultures were stimulated
1 h later with LPS ( ) at 1 ng/ml, 506 ( ) at 1 ng/ml, and
GLA-60 ( ) at 100 ng/ml. The amounts of NO, TNF- , and IL-6 in the
culture supernatants at 48 h after stimulation were determined.
The data are the means ± SEM of triplicate samples. A
representative result of three independent experiments is shown.
|
|
PTX, a methylxanthine compound, has been reported to inhibit TNF-

secretion, but not IL-6 secretion, from LPS-stimulated
monocytic cells
(
22,
23). In the next experiment, RAW264.7
cells were
stimulated with LPS, 506, or GLA-60 in the presence
of PTX, and the
production of NO, TNF-

, and IL-6 in the culture
supernatant was
measured. Neither the production of NO nor that
of IL-6 was suppressed,
while a suppressive effect of PTX on TNF-
synthesis was clearly
observed (Fig.
5). These results indicate
that TNF-

does not participate in the signaling pathways for
the
production of NO and IL-6.

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 5.
Effect of PTX on production of mediators by RAW264.7
cells upon stimulation with LPS and its agonists. The indicated
concentrations of PTX were added to cultures of RAW264.7 cells 1 h
before stimulation with LPS at 1 ng/ml, 506 at 1 ng/ml, and GLA-60 at
100 ng/ml. The amounts of NO, TNF- and IL-6 in the culture
supernatants at 48 h after stimulation were determined. The data
are the means ± SEM of triplicate samples. A representative
result of two independent experiments is shown.
|
|
Effect of anti-IL-6 antibody on production of NO and TNF-
by
stimulation with LPS, 506, or GLA-60.
To investigate the effect of
IL-6 on the production of NO upon stimulation with LPS agonists,
RAW264.7 cells were stimulated with LPS, 506, or GLA-60 in the presence
of anti-mouse IL-6 antibody, and the amounts of NO in the culture
supernatant were measured. In addition, the activities of TNF-
and
IL-6 in the culture supernatant were determined. As shown in Fig.
6, the production of NO and TNF-
were
not affected by the antibody under the conditions under which the
antibody significantly suppressed IL-6 activity in the culture
supernatant. These results indicated that IL-6 induced by the stimuli
has no effect on the signaling pathways for the production of NO and
TNF-
.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 6.
Effect of anti-IL-6 antibody on production of mediators
by RAW264.7 cells upon stimulation with LPS and its agonists. The
experimental procedures were the same as those described in the legend
to Fig. 4, except for the antibody used (anti-mouse IL-6 antibody) and
its concentrations. The data are the means ± SEM of triplicate
samples. Similar results were obtained in another independent
experiment.
|
|
Inhibition of production of the mediators by an inactive lipid A
analogue, GLA-58.
A monosaccharide lipid A analogue, GLA-58,
showed no activity to induce any of the three mediators examined in
this study (Fig. 3). To investigate the antagonistic effect of this
compound, RAW264.7 cells were cultured in the presence of the compound
and stimulated with LPS, 506, or GLA-60. We observed dose-dependent inhibition by GLA-58 of the production of NO, TNF-
, and IL-6 induced
by all three stimulants (Fig. 7). Unlike
suppression by cytokine-specific antibodies or PTX, production of all
three mediators was simultaneously suppressed by GLA-58. When RAW264.7
cells were stimulated by agents unrelated to LPS, such as zymosan A
(Sigma), no inhibitory effect of GLA-58 on the production of NO,
TNF-
, or IL-6 was observed (data not shown), indicating that the
inhibitory effect of GLA-58 is not the result of its cytotoxic action
on RAW264.7 cells.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 7.
Inhibitory effect of GLA-58 on production of mediators
by RAW264.7 cells upon stimulation with LPS and its agonists. RAW264.7
cells were cultured in the presence of the indicated concentrations of
GLA-58. Two hours later, LPS at 1 ng/ml, 506 at 1 ng/ml, and GLA-60 at
1 µg/ml were added to the cultures to stimulate the cells. The
amounts of NO, TNF- , and IL-6 in the culture supernatants at 48 h after stimulation were determined. The data are the means ± SEM
of triplicate samples. Similar results were obtained in another
independent experiment.
|
|
 |
DISCUSSION |
In the present study, we found that the relationships of the
structures and activities of monosaccharide lipid A analogues in the
induction of NO synthesis by murine macrophage RAW264.7 cells
correlates very well with those in the production of proinflammatory cytokines, such as TNF-
and IL-6. Among the analogues tested, GLA-60, which possesses three acyl groups and one phosphate group to
one saccharide backbone, exhibited the strongest activities to induce
NO synthesis as well as TNF-
and IL-6 production. Strong activities
similar to those of GLA-60 were exhibited by GLA-59, which is
constituted with the same components as GLA-60 but with a different
linkage pattern of acyl groups. The ratio of phosphate groups and acyl
groups to one saccharide backbone of these analogues (1:3:1) is the
same as that of 506 (2:6:2 = 1:3:1), which has the complete
disaccharide structure of active lipid A (Escherichia coli
type) and the strongest activities among the disaccharide analogues so
far synthesized. More-hydrophilic analogues with two acyl groups, like
GLA-26, and more-hydrophobic analogues with four acyl groups, like
GLA-47, were less active than GLA-60. Even triacylated monosaccharide
analogues, GLA-69 and GLA-58, are more hydrophobic than GLA-60 because
they have one longer acyl group (C16) and a dehydroxylated
acyl group (C14) as components, and their activities were
much weaker than those of GLA-60. Dehydroxylation of GLA-60 alone
decreased the activities slightly, and lengthening the acyl chain of
GLA-60 to C16 alone strongly decreased the activities, although less strongly than when both factors were changed
simultaneously, as was the case for GLA-69 (data not shown). These
results indicate that such a hydrophobe-hydrophile balance of the
molecules plays an important role in the stimulation of the LPS
receptor(s) to transduce signals for the production of NO as well as
TNF-
and IL-6, and they support the concept that a balanced ratio of
hydrophobicity and hydrophilicity is involved in the expression of
endotoxic activity (20).
Based on the results of the time course study shown in Fig. 1, the
possibility of NO production via TNF-
and/or IL-6 production was
considered. However, this was found to be unfeasible, through experiments using antibodies to neutralize the activity of the cytokines (Figs. 4 and 6) and an experiment using PTX to suppress the
production of TNF-
(Fig. 5). Considering the well-correlated production of the three mediators, signaling pathways for NO production may share some common parts with those for production of TNF-
and
IL-6 in the early stages, and the intensity of signals to produce these
three mediators may be determined before the pathways branch to
individual ones. In the case of LPS-derived NO production by murine
macrophages, inducible NO synthase (iNOS), one of three isoforms of NO
synthase, is known to play a role as the catalytic enzyme of NO
production from L-arginine (25). Induction of
iNOS gene expression and production of iNOS protein are therefore
prerequisites for LPS-derived NO production. For the induction of iNOS
gene expression, LPS-derived activation of a transcription factor, nuclear factor-
B (NF-
B), which translocates from the cytosol to
the nucleus and binds to region 1 in the promoter of the iNOS gene, was
reported to play an important role (27). Many LPS-responsive genes, including those of TNF-
and IL-6, are known to share
recognition sequences that can be recognized by NF-
B for the
activation of gene expression (26). In addition to NF-
B,
transcription factors such as NF-IL-6 and activator protein-1
(2) are also known to be activated and to interact with each
other in LPS response in macrophages (26). Some common
transcription factors activated by LPS and lipid A analogues may play
key roles in the expression of all three genes for iNOS, TNF-
, and
IL-6. After activation of the expression of these genes, signals for
production of each mediator may be transduced independently.
We have previously reported that GLA-58 has the ability to protect mice
from LPS lethality under D-galactosamine-sensitized conditions (in vivo protective activity) and that, after pretreatment of murine macrophages with the analogue and washing it out, it also has
potency to lead the macrophages into a state that is hyporesponsive to
LPS stimulation (in vitro tolerance-inducing activity) (15).
In the present study, this analogue showed another ability as an
inhibitor (antagonistic activity) to LPS, 506, and GLA-60 for
production of NO, TNF-
, and IL-6 when it coexisted with the
stimulants (Fig. 7). This was in contrast to the specific suppression
of TNF-
by PTX. The broad inhibitory activity of GLA-58 to
production of multiple mediators, however, is not due to its
cytotoxicity to macrophages, since no such inhibitory activity of
GLA-58 was observed when macrophages were stimulated with agents unrelated to LPS, like zymosan A. These results suggest that GLA-58 acts negatively on the signaling pathways of LPS agonists in the early
stages before branching into the signals for NO, TNF-
, and IL-6 production.
The present study indicates that the signaling pathways of LPS agonists
for NO production in murine macrophages are regulated in good
correlation with those for the production of proinflammatory cytokines,
such as TNF-
and IL-6, although the cytokines do not participate in
the signals for NO production.
 |
ACKNOWLEDGMENT |
This work was supported in part by grant 09670295 from the
Ministry of Education, Science and Culture of Japan.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, Jichi Medical School, 3311-1, Yakushiji,
Minamikawachi-machi, Tochigi 329-0498, Japan. Phone: 81-285-58-7332. Fax: 81-285-44-1175. E-mail: mmatsuur{at}jichi.ac.jp.
Deceased 10 October 1996.
Editor:
J. R. McGhee
 |
REFERENCES |
| 1.
|
Aarden, L. A.,
E. R. de Groot,
O. L. Shaap, and P. M. Lansdorp.
1987.
Production of hybridoma growth factor by human monocytes.
Eur. J. Immunol.
7:1411-1416.
|
| 2.
|
Dendorfer, U.,
P. Oettgen, and T. A. Libermann.
1994.
Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide.
Mol. Cell. Biol.
14:4443-4454[Abstract/Free Full Text].
|
| 3.
|
Flad, H.-D.,
H. Loppnow,
E. T. Rietschel, and A. J. Ulmer.
1993.
Agonists and antagonists for lipopolysaccharide-induced cytokines.
Immunobiology
187:303-316[Medline].
|
| 4.
|
Galanos, C.,
O. Lüderitz,
E. T. Rietschel,
O. Westphal,
H. Brade,
L. Brade,
M. Freudenberg,
U. Shade,
M. Imoto,
H. Yoshimura,
S. Kusumoto, and T. Shiba.
1985.
Synthetic and natural Escherichia coli lipid A express identical endotoxic activities.
Eur. J. Biochem.
148:1-5[Medline].
|
| 5.
|
Galanos, C.,
O. Lüderitz, and O. Westphal.
1979.
Preparation and properties of a standardized lipopolysaccharide from Salmonella abortus equi.
Zentbl. Bakteriol. Mikrobiol. Hyg. 1 Abt. Orig. A
243:226-244.
|
| 6.
|
Green, S. J.,
D. A. Wagner,
J. Glogowski,
P. L. Skipper,
J. S. Wishnok, and S. R. Tannenbaum.
1982.
Analysis of nitrite, and [15N]nitrate in biological fluids.
Anal. Biochem.
126:131-138[Medline].
|
| 7.
|
Homma, J. Y.,
M. Matsuura,
S. Kanegasaki,
Y. Kawakubo,
Y. Kojima,
N. Shibukawa,
Y. Kumazawa,
A. Yamamoto,
K. Tanamoto,
T. Yasuda,
M. Imoto,
H. Yoshimura,
S. Kusumoto, and T. Shiba.
1985.
Structural requirements of lipid A responsible for the functions: a study with chemically synthesized lipid A and its analogues.
J. Biochem.
98:395-406[Abstract/Free Full Text].
|
| 8.
|
Homma, J. Y.,
M. Matsuura, and Y. Kumazawa.
1989.
Studies on lipid A, the active center of endotoxin structure-activity relationship.
Drugs Future
14:645-665.
|
| 9.
|
Kiso, M.,
S. Tanaka,
M. Fujishima,
Y. Ogawa, and A. Hasegawa.
1987.
Synthesis of nonreducing sugar subunit analogues of bacterial lipid A carrying an amide-bound (3R)-3-acyloxytetradecanoyl group.
Carbohydr. Res.
162:247-256.
|
| 10.
|
Kiso, M.,
S. Tanaka,
M. Fujita,
Y. Fujishima,
Y. Ogawa,
H. Ishida, and A. Hasegawa.
1987.
Synthesis of the optically active 4-O-phosphono-D-glucosamine derivatives related to the non-reducing sugar subunit of bacterial lipid A.
Carbohydr. Res.
162:127-140[Medline].
|
| 11.
|
Kotani, S.,
H. Takada,
M. Tsujimoto,
T. Ogawa,
I. Takahashi,
T. Ikeda,
K. Otsuka,
H. Shimauchi,
N. Kasai,
J. Mashimo,
S. Nagao,
A. Tanaka,
S. Tanaka,
K. Harada,
K. Nagaki,
H. Kitamura,
T. Shiba,
S. Kusumoto,
M. Imoto, and H. Yoshimura.
1985.
Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli Re-mutant.
Infect. Immun.
49:225-237[Abstract/Free Full Text].
|
| 12.
|
Kumazawa, Y.,
M. Nakatsuka,
H. Takimoto,
T. Furuya,
T. Nagumo,
A. Yamamoto,
J. Y. Homma,
K. Inada,
M. Yoshida,
M. Kiso, and A. Hasegawa.
1988.
Importance of fatty acid substituents of chemically synthesized lipid A-subunit analogues in the expression of immunopharmacological activity.
Infect. Immun.
56:149-155[Abstract/Free Full Text].
|
| 13.
|
Manthey, C. L., and S. N. Vogel.
1992.
The role of cytokines in host response to endotoxin.
Rev. Med. Microbiol.
80:146-159.
|
| 14.
|
Matsuura, M.,
Y. Kijima,
J. Y. Homma,
Y. Kubota,
N. Shibukawa,
M. Shibata,
M. Inage,
S. Kusumoto, and T. Shiba.
1983.
Interferon-inducing, pyrogenic and proclotting enzyme of horseshoe crab activation activities of chemically synthesized lipid A analogues.
Eur. J. Biochem.
137:639-642[Medline].
|
| 15.
|
Matsuura, M.,
M. Kiso,
A. Hasegawa, and M. Nakano.
1994.
Multistep regulation mechanisms for tolerance induction to lipopolysaccharide lethality in the tumor-necrosis-factor- -mediated pathway. Application of non-toxic monosaccharide lipid A analogues for elucidation of mechanisms.
Eur. J. Biochem.
221:335-341[Medline].
|
| 16.
|
Matsuura, M.,
S. Shimada,
M. Kiso,
A. Hasegawa, and M. Nakano.
1995.
Expression of endotoxic activities by synthetic monosaccharide lipid A analogs with alkyl-branched acyl substituents.
Infect. Immun.
63:1446-1451[Abstract].
|
| 17.
|
Moncada, S.,
R. M. Palmer, and E. A. Higgs.
1991.
Nitric oxide: physiology, pathophysiology, and pharmacology.
Pharmacol. Rev.
43:109-142[Medline].
|
| 18.
|
Morrison, D. C., and J. L. Ryan.
1987.
Endotoxins and disease mechanisms.
Annu. Rev. Med.
38:417-432[Medline].
|
| 19.
|
Mosman, T.
1983.
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays.
J. Immunol. Methods
65:55-63[Medline].
|
| 20.
|
Rietschel, E. T.,
H. Brade,
L. Brade,
K. Brandenburg,
U. Schade,
U. Seydel,
U. Zähringer,
C. Galanos,
O. Lüderitz,
O. Westphal,
H. Labishenski,
S. Kusumoto, and T. Shiba.
1987.
Lipid A, the endotoxic center of bacterial lipopolysaccharides: relation of chemical structure to biological activity.
Prog. Clin. Biol. Res.
231:25-53[Medline].
|
| 21.
|
Ruff, M. R., and G. E. Gifford.
1980.
Purification and physiological characterization of rabbit tumor necrosis factor.
J. Immunol.
125:1671-1677[Abstract].
|
| 22.
|
Schandene, L.,
P. Vabdenbussche,
A. Crusiaux,
M.-L. Alègre,
D. Abramowicz,
E. Dupont,
J. Content, and M. Goldman.
1992.
Differential effects of pentoxifylline on the production of TNF-alpha and IL-6 by monocytes and T cells.
Immunology
76:30-34[Medline].
|
| 23.
|
Strieter, R. M.,
D. G. Remick,
P. A. Ward,
R. N. Spengler,
I. Lynch,
J. Larrick, and S. L. Kunkel.
1988.
Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline.
Biochem. Biophys. Res. Commun.
30:1230-1236.
|
| 24.
|
Stuehr, D. J., and M. A. Marletta.
1987.
Synthesis of nitrite and nitrate in murine macrophage cell lines.
Cancer Res.
47:5590-5594[Abstract/Free Full Text].
|
| 25.
|
Stuehr, D. J., and C. F. Nathan.
1989.
Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells.
J. Exp. Med.
169:1543-1555[Abstract/Free Full Text].
|
| 26.
|
Sweet, M. J., and D. A. Hume.
1996.
Endotoxin signal transduction in macrophages.
J. Leukoc. Biol.
60:8-26[Abstract].
|
| 27.
|
Xie, Q.-W.,
Y. Kashiwabara, and C. Nathan.
1994.
Role of transcription factor NF- B/Rel in induction of nitric oxide synthase.
J. Biol. Chem.
269:4705-4708[Abstract/Free Full Text].
|
Infection and Immunity, December 1998, p. 5792-5798, Vol. 66, No. 12
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Hu, K., Lv, Q., Cui, F.Z., Xu, L., Jiao, Y.P., Wang, Y., Feng, Q.L., Wang, H.L., Huang, L.Y.
(2007). A Novel Poly(L-lactide) (PLLA)/Fibroin Hybrid Scaffold to Promote Hepatocyte Viability and Decrease Macrophage Responses. Journal of Bioactive and Compatible Polymers
22: 395-410
[Abstract]
-
Bailey, L. O., Weir, M. D., Washburn, N. R.
(2006). Quantification of Macrophage Viability and Inflammatory Response to Dental Bonding Resins. Journal of Bioactive and Compatible Polymers
21: 185-206
[Abstract]
-
Matsuura, M., Kiso, M., Hasegawa, A.
(1999). Activity of Monosaccharide Lipid A Analogues in Human Monocytic Cells as Agonists or Antagonists of Bacterial Lipopolysaccharide. Infect. Immun.
67: 6286-6292
[Abstract]
[Full Text]